Search

Author/Creator McKee, Mark D

1. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Issue 4 (April 2018)

Authors:
Loibl, Sibylle; O'Shaughnessy, Joyce; Untch, Michael; Sikov, William M; Rugo, Hope S; McKee, Mark D; Huober, Jens; Golshan, Mehra; von Minckwitz, Gunter; Maag, David; Sullivan, Danielle; Wolmark, Norman; McIntyre, Kristi; Ponce Lorenzo, Jose J; Metzger Filho, Otto; Rastogi, Priya; Symmans, W Fras...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 4(2018)
Page Start:
497
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search